2 assets in Hypersensitivity Pneumonitis

Therapeutic assets addressing Hypersensitivity Pneumonitis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
XENON Hypersensitivity Pneumonitis	University of Kansas Medical Center	P2	CCC (53)
Fapi-46 Hypersensitivity Pneumonitis	University of California, Los Angeles	Early P1	C (39)